Miragen Therapeutics, Inc.

/Miragen Therapeutics, Inc.

They are a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their roles in diseases where there is a high unmet medical need.


Price Range
$8.60 - $6.52

Anticipated Shares

Effective Date
February 9, 2018


To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange